Rheumer Has It: Our Most Exciting Takeaways from the ACR 2025 Rheumatology Conference
On this episode of 'Rheumer Has It,' Eileen and Cheryl delve into the latest advancements and key takeaways from the American College of Rheumatology's Annual Conference. They discuss groundbreaking treatments like CAR T-cell therapy, Neuroimmodulators like Vagus Nerve Stimulator Devices, GLP-1 medications
Audio is streamed directly from the publisher (afp-935238-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
They also reflect on new insights into mental health, cognitive dysfunction, and the importance of the microbiome as part of lifestyle interventions. This episode offers hope, practical advice, and the latest research to help manage your condition more effectively.
Episode at a glance:
- 00:00 Introduction to Rheumer Has It
- 00:30 Importance of the ACR Annual Conference
- 03:02 Sessions on Patient Health Literacy and Support Groups
- 07:10 Dietary Interventions and Microbiome Research
- 10:54 Mental Health and Fatigue in Rheumatic Diseases
- 15:50 Innovative Treatments: CAR T-Cell Therapy and Vagus Nerve Stimulation
- 19:50 GLP-1 Medications and Their Benefits
- 25:23 Cognitive Dysfunction in Rheumatic Diseases
- 29:22 Spotlight on Sjogren's Disease
- 31:50 Conclusion and Key Takeaways
Medical disclaimer:
All content found on Arthritis Life public channels (including Rheumer Has It) was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
Episode Sponsors
Rheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.